Pensionfund Sabic Takes Position in Waters Co. (NYSE:WAT)


Share on StockTwits

Pensionfund Sabic bought a new stake in Waters Co. (NYSE:WAT) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 7,100 shares of the medical instruments supplier’s stock, valued at approximately $2,018,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. DekaBank Deutsche Girozentrale lifted its holdings in Waters by 10.3% during the 4th quarter. DekaBank Deutsche Girozentrale now owns 99,805 shares of the medical instruments supplier’s stock worth $24,555,000 after buying an additional 9,280 shares during the last quarter. Amundi Pioneer Asset Management Inc. increased its position in shares of Waters by 42.8% during the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 121,742 shares of the medical instruments supplier’s stock worth $30,122,000 after purchasing an additional 36,462 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of Waters during the fourth quarter worth about $1,195,000. Dimensional Fund Advisors LP increased its position in shares of Waters by 4.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 270,348 shares of the medical instruments supplier’s stock worth $66,886,000 after purchasing an additional 10,427 shares in the last quarter. Finally, Eaton Vance Management increased its position in shares of Waters by 13.5% during the fourth quarter. Eaton Vance Management now owns 23,405 shares of the medical instruments supplier’s stock worth $5,791,000 after purchasing an additional 2,784 shares in the last quarter. 91.80% of the stock is owned by institutional investors.

NYSE:WAT opened at $296.35 on Thursday. The firm has a 50-day moving average of $275.95 and a two-hundred day moving average of $247.40. The stock has a market cap of $18.43 billion, a P/E ratio of 36.91, a PEG ratio of 8.79 and a beta of 0.97. Waters Co. has a 1-year low of $171.38 and a 1-year high of $304.49.

Waters (NYSE:WAT) last issued its quarterly earnings results on Monday, February 1st. The medical instruments supplier reported $3.65 EPS for the quarter, topping the consensus estimate of $2.89 by $0.76. Waters had a net margin of 22.61% and a negative return on equity of 349.31%. The business had revenue of $786.66 million for the quarter, compared to analysts’ expectations of $711.10 million. During the same quarter last year, the company posted $3.20 earnings per share. On average, analysts predict that Waters Co. will post 7.94 earnings per share for the current year.

Several brokerages recently issued reports on WAT. Smith Barney Citigroup upgraded Waters from a “sell” rating to a “neutral” rating in a research report on Wednesday, December 16th. TheStreet upgraded Waters from a “c” rating to an “a-” rating in a research report on Tuesday, February 2nd. Citigroup boosted their target price on Waters from $250.00 to $300.00 in a research report on Wednesday, February 3rd. Wells Fargo & Company cut Waters from an “equal weight” rating to an “underweight” rating and set a $235.00 target price on the stock. in a research report on Thursday, January 7th. Finally, Cleveland Research upgraded Waters from an “underperform” rating to a “buy” rating in a research report on Thursday, December 17th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the company. The company has an average rating of “Hold” and an average price target of $225.27.

In other Waters news, Director Joann A. Reed sold 1,600 shares of Waters stock in a transaction that occurred on Friday, March 5th. The shares were sold at an average price of $263.31, for a total value of $421,296.00. Also, Director Joann A. Reed sold 4,759 shares of Waters stock in a transaction that occurred on Tuesday, February 9th. The stock was sold at an average price of $282.39, for a total transaction of $1,343,894.01. Following the completion of the transaction, the director now owns 36,683 shares in the company, valued at approximately $10,358,912.37. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by company insiders.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also: Hedge Funds

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.